Miliary tuberculosis medical therapy: Difference between revisions
(Created page with "__NOTOC__ {{Miliary tuberculosis}} {{CMG}} ==Overview== ==Medical Therapy== :''See:'' Tuberculosis treatment Miliary TB is a serious condition; untreated miliary TB is al...") |
No edit summary |
||
Line 13: | Line 13: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Needs overview]] | |||
{{WH}} | |||
{{WS}} |
Revision as of 15:45, 21 November 2012
Miliary tuberculosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Miliary tuberculosis medical therapy On the Web |
American Roentgen Ray Society Images of Miliary tuberculosis medical therapy |
Risk calculators and risk factors for Miliary tuberculosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Miliary TB is a serious condition; untreated miliary TB is almost always fatal. About 25% of patients with miliary TB also have tuberculous meningitis. The standard treatment recommended by the WHO is with isoniazid and rifampicin for six months, as well as ethambutol and pyrazinamide for the first two months. If there is evidence of meningitis, then treatment is extended to twelve months. The US guidelines recommend nine months' treatment.